Yahoo Web Search

Search results

    • Q1 2024 Panbela Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 21 hours ago

      And in 2025, early on, we anticipate overall survival interim analysis for our Phase III ASPIRE trial in the first quarter and the opening of the non-small cell lung cancer Phase II trial in ...